13 August 2020 - Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing financial burden for many patients, according to a new analysis.
Since 2009, the annual mean increase in price ranged from 4% to 12% for nine different psoriasis medicines, although some of the drugs were launched more recently.
For instance, the largest rise in wholesale price was for Cimzia, which exceeded $94,000 last year, compared with just under $40,000 when the drug became available 11 years ago.